This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Author information
Author notes
Fariba Fischel Ghodsian is vice president and biotechnology/phar-maceuticals analyst at Wedbush Morgan Securities (Los Angeles, CA). Darby Heidemann, a research assistant at Webush Morgan Securities, contributed to this commentary.
- Fariba Fischel Ghodsian
Rights and permissions
About this article
Cite this article
Ghodsian, F. In all, Wall Street supports biotech acquisitions. Nat Biotechnol 13, 729–730 (1995). https://doi.org/10.1038/nbt0895-729
Issue Date:
DOI: https://doi.org/10.1038/nbt0895-729